Marker Therapeutics, Inc. (MRKR)
1.50
+0.11
(+7.91%)
USD |
NASDAQ |
Aug 24, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Total Assets (Quarterly) : 14.59M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.59M |
| March 31, 2026 | 17.43M |
| December 31, 2025 | 19.07M |
| September 30, 2025 | 21.73M |
| June 30, 2025 | 14.77M |
| March 31, 2025 | 16.99M |
| December 31, 2024 | 22.02M |
| September 30, 2024 | 10.91M |
| June 30, 2024 | 11.68M |
| March 31, 2024 | 14.09M |
| December 31, 2023 | 17.13M |
| September 30, 2023 | 19.49M |
| June 30, 2023 | 21.96M |
| March 31, 2023 | 27.94M |
| December 31, 2022 | 34.42M |
| September 30, 2022 | 41.11M |
| June 30, 2022 | 52.32M |
| March 31, 2022 | 54.96M |
| December 31, 2021 | 68.14M |
| September 30, 2021 | 71.94M |
| June 30, 2021 | 80.47M |
| March 31, 2021 | 88.36M |
| December 31, 2020 | 45.61M |
| September 30, 2020 | 48.57M |
| June 30, 2020 | 48.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 42.89M |
| December 31, 2019 | 46.36M |
| September 30, 2019 | 51.40M |
| June 30, 2019 | 55.00M |
| March 31, 2019 | 58.99M |
| December 31, 2018 | 62.14M |
| September 30, 2018 | 4.391M |
| June 30, 2018 | 7.892M |
| March 31, 2018 | 2.930M |
| December 31, 2017 | 5.180M |
| September 30, 2017 | 7.704M |
| June 30, 2017 | 10.14M |
| March 31, 2017 | 6.105M |
| December 31, 2016 | 7.921M |
| September 30, 2016 | 9.698M |
| June 30, 2016 | 3.789M |
| March 31, 2016 | 5.759M |
| December 31, 2015 | 6.645M |
| September 30, 2015 | 6.225M |
| June 30, 2015 | 3.248M |
| March 31, 2015 | 1.536M |
| December 31, 2014 | 0.2244M |
| September 30, 2014 | 0.6436M |
| June 30, 2014 | 0.0357M |
| March 31, 2014 | 0.1094M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.501B |
| Tenaya Therapeutics, Inc. | 93.54M |
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Vericel Corp. | 502.87M |
| SELLAS Life Sciences Group, Inc. | 145.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.42M |
| Shareholders Equity (Quarterly) | 12.17M |
| Current Ratio | 6.027 |